feed,title,long_url,short_url
Benzinga,"Equillium's Itolizumab Shows Encouraging Safety, Tolerability Profile In Systemic Lupus Erythematosus Study",https://benzinga.com/general/biotech/21/03/20419128/equilliums-itolizumab-shows-encouraging-safety-tolerability-profile-in-systemic-lupus-erythematos,https://j.mp/2PeRLE8
